ES2099067T3 - Nuevos acidos carboxilicos azaheterociclicos sustituidos en n. - Google Patents

Nuevos acidos carboxilicos azaheterociclicos sustituidos en n.

Info

Publication number
ES2099067T3
ES2099067T3 ES89123400T ES89123400T ES2099067T3 ES 2099067 T3 ES2099067 T3 ES 2099067T3 ES 89123400 T ES89123400 T ES 89123400T ES 89123400 T ES89123400 T ES 89123400T ES 2099067 T3 ES2099067 T3 ES 2099067T3
Authority
ES
Spain
Prior art keywords
azahetero
new substituted
substituted
carboxyl acids
pyrrolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89123400T
Other languages
English (en)
Inventor
Lars Jacob Stray Knutsen
Anker Steen Jorgensen
Knud Erik Andersen
Ursula Sonnewald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2099067T3 publication Critical patent/ES2099067T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Bipolar Transistors (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

NUEVOS ACIDOS CARBOXILICOS AZAHETEROCICLICO SUSTITUIDO-N Y ESTERES DE ELLO EN EL QUE UN GRUPO ETER FORMA PARTE DEL SUSTITUYENTE-N, LOS COMPONENTES ASI FORMADOS TIENEN LA FORMULA GENERAL I EN DONDE R1 Y R2 SON EL MISMO O DIFERENTE Y CADA UNO REPRESENTA FENIL, TIENIL-2 O TIENIL-3, PIRROLIL-2 O PIRROLIL-3, SUSTITUIDO CON UNO O MAS SUSTITUYENTES SELECCIONADOS ENTRE LOS SIGUIENTES ATOMOS O GRUPOS: HIDROGENO, HALOGENO, ALQUIL C1-C6, ALCOXI C1-6, O CIANO; R3 Y R4 CADA UNO REPRESENTA HIDROGENO O JUNTOS REPRESENTAN UN ENLACE; M ES 1 O 2 Y N ES 1 CUANDO M ES 1 Y N ES 0 CUANDO M ES 2; R5 Y R6 CADA UNO REPRESENTA HIDROGENO O DEBE -CUANDO M ES 2- JUNTOS REPRESENTAN UN ENLACE, Y R7 ES OH O ALCOXI C1-8, P ES 0 O 1 O 2, Q ES 0 O 1 O 2, R8 ES H Y ALQUIL C1-4, SON INHIBIDORES POTENTES DE LA SALIDA GABA DE LA HENDIDURA SINAPTICA.
ES89123400T 1988-12-19 1989-12-18 Nuevos acidos carboxilicos azaheterociclicos sustituidos en n. Expired - Lifetime ES2099067T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK704488A DK704488D0 (da) 1988-12-19 1988-12-19 Nye n-substituerede azaheterocykliske carboxylsyrer

Publications (1)

Publication Number Publication Date
ES2099067T3 true ES2099067T3 (es) 1997-05-16

Family

ID=8149197

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89123400T Expired - Lifetime ES2099067T3 (es) 1988-12-19 1989-12-18 Nuevos acidos carboxilicos azaheterociclicos sustituidos en n.

Country Status (16)

Country Link
US (1) US5071859A (es)
EP (1) EP0374801B1 (es)
JP (1) JP2848534B2 (es)
AT (1) ATE150455T1 (es)
AU (1) AU634992B2 (es)
CA (1) CA2005919C (es)
DE (1) DE68927875T2 (es)
DK (1) DK704488D0 (es)
ES (1) ES2099067T3 (es)
FI (1) FI93951C (es)
GR (1) GR3023379T3 (es)
IL (1) IL92652A0 (es)
NO (1) NO177672C (es)
NZ (1) NZ231836A (es)
PT (1) PT92628B (es)
ZA (1) ZA899736B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
DE3609699A1 (de) * 1986-03-20 1987-09-24 Schering Ag 5- oder 6-substituierte-(beta)-carbolin-3-carbonsaeureester
US5214054A (en) * 1988-05-18 1993-05-25 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
FR2653123B1 (fr) * 1989-10-17 1992-01-17 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
DE4117904A1 (de) * 1991-05-31 1992-12-03 Basf Ag Substituierte n-phenylpiperidine
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer
EP0535496A1 (en) * 1991-09-25 1993-04-07 Hoechst-Roussel Pharmaceuticals Incorporated (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments
EP0767174A1 (de) * 1991-11-21 1997-04-09 Ciba-Geigy Ag Neue Aminoalkanphosphinsäuren und ihre Salze
US5932596A (en) * 1991-12-18 1999-08-03 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing nitrogen containing heterocyclic ring
US5633250A (en) * 1991-12-18 1997-05-27 Schering Corporation Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
US5807872A (en) * 1992-12-16 1998-09-15 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
SG44510A1 (en) * 1991-12-18 1997-12-19 Schering Corp Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
GB9127306D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5286733A (en) * 1992-11-20 1994-02-15 Sterling Winthrop Inc. Substituted 3-piperidinealkanoates and alkanones and compositions and method of use thereof
US5580877A (en) * 1994-04-25 1996-12-03 Merck Sharp & Dohme Ltd. Pyrazolo-quinoline derivatives for treating cerebral ischemia
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
FR2735476B1 (fr) * 1995-06-14 1997-07-18 Rhone Poulenc Rorer Sa Nouvelle application de derives du pyrrole
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives
WO1999031056A1 (fr) * 1997-12-12 1999-06-24 Toyama Chemical Co., Ltd. Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant
DE19840611A1 (de) * 1998-09-05 2000-03-09 Klaus Wanner GABA-uptake-Inhibitoren mit Pyrrolidinstruktur
US7026335B2 (en) * 2002-04-30 2006-04-11 The Procter & Gamble Co. Melanocortin receptor ligands
US20040010010A1 (en) * 2002-04-30 2004-01-15 Ebetino Frank Hallock Melanocortin receptor ligands
MX2022016223A (es) * 2020-07-02 2023-02-23 Sea Pharmaceuticals Llc Composiciones farmaceuticas de acido 6-(2-(2h-tetrazol-5-il)etil)- 6-fluorodecahidroisoquinolina-3-carboxilico y derivados de ester del mismo.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
FI83957C (fi) * 1984-09-28 1991-09-25 Byk Gulden Lomberg Chem Fab Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara diarylfoereningar.
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DE3787657T2 (de) * 1986-01-07 1994-02-03 Novo Ind A S Bagsvaerd Aminosäure-Derivate.
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer

Also Published As

Publication number Publication date
PT92628B (pt) 1995-09-12
CA2005919C (en) 1997-01-07
JP2848534B2 (ja) 1999-01-20
NO895093D0 (no) 1989-12-18
FI93951C (fi) 1995-06-26
NO895093L (no) 1990-06-20
ZA899736B (en) 1990-09-26
FI896084A0 (fi) 1989-12-19
EP0374801A2 (en) 1990-06-27
EP0374801A3 (en) 1991-08-07
DE68927875D1 (de) 1997-04-24
NO177672B (no) 1995-07-24
US5071859A (en) 1991-12-10
PT92628A (pt) 1990-06-29
ATE150455T1 (de) 1997-04-15
JPH02223551A (ja) 1990-09-05
FI93951B (fi) 1995-03-15
DK704488D0 (da) 1988-12-19
EP0374801B1 (en) 1997-03-19
GR3023379T3 (en) 1997-08-29
DE68927875T2 (de) 1997-06-26
NO177672C (no) 1995-11-01
CA2005919A1 (en) 1990-06-19
IL92652A0 (en) 1990-08-31
AU634992B2 (en) 1993-03-11
NZ231836A (en) 1992-11-25
AU4688989A (en) 1990-06-21

Similar Documents

Publication Publication Date Title
ES2099067T3 (es) Nuevos acidos carboxilicos azaheterociclicos sustituidos en n.
ES8600305A1 (es) Procedimiento de preparar compuestos beta-lactamicos
NO164574C (no) Antimikrobielle blandinger paa basis av fenoksyarsiner.
PL299559A1 (en) Cyclic inhibitor of cell conglutination
DE10299030I1 (de) Verbeserungen in Zusammensetzungen von kopolymeren enthaltend Kopolymer-1
EA200501267A1 (ru) Жирные кислоты со средней длиной цепи, глицериды и аналоги в качестве стимуляторов эритропоэза
AU631070B2 (en) Novel platelet-aggregation inhibitor
DE69020676D1 (de) Tricyclische Carbapenemverbindungen.
ES2110213T3 (es) Derivado de n-acilglutamina.
EP0652211A4 (en) PROSTAGLANDIN DERIVATIVE.
KR900006380A (ko) 그래프트 공중합체의 제조방법
SI0668279T1 (en) 6-Azaindole thromboxane synthase inhibitors
CO5011097A1 (es) Derivados de 8-azabiciclo [3.2.1]octan-3-metanamina .
DE69732979D1 (de) Holzkonservierung unter verwendung polymerer phenolsulfide
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
FI890293A (fi) Foerfarande foer framstaellning av tioformamidderivat.
ES2075326T3 (es) Composiciones fungicidas que contienen sales de tris(aril)-fosfonio.
DE69018058D1 (de) Verfahren zur Debrominierung von 2-substituierten-5-Bromo-6-Methoxynaphthalenen.
SE9704137D0 (sv) Water tree retarding additive
ES2082941T3 (es) Inhibidores de la corrosion a base de borato calcico/carboxilato de amino.
SE9802371D0 (sv) Tillsats och komposition för belagt papper och belagt papper erhållet med användning av desamma
TH31611A (es)
GB9617822D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 374801

Country of ref document: ES